TABLE 2 from Low-dose Paclitaxel with Pembrolizumab Enhances Clinical and Immunologic Responses in Platinum-refractory Urothelial Carcinoma
收藏NIAID Data Ecosystem2026-05-01 收录
数据链接：
官方服务：
资源简介：
All grade 3 or higher treatment-related AEs for subjects receiving at least one dose of combination therapy. Grade 2 treatment-related AES are included if >10% frequency
创建时间：
2024-02-26
